Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study - Concepedia

Concepedia

Publication | Open Access

Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study

DOI Full Paper Access

165

Citations

10

References

2015

Year

Anita Kohli, Rama Kapoor, Zayani Sims, Amy Nelson, Sreetha Sidharthan, Brian Lam, Rachel Silk, Colleen Kotb, Chloe Gross, Gebeyehu Teferi,

The Lancet Infectious Diseases

HepatologyHepatitis CViral HepatitisGenetic EpidemiologyAntiviral TherapyHepatitisVirologyOpen-label Phase 2ACohort StudyLiver DiseaseChronic Viral InfectionPublic HealthMedicineEpidemiology

References

	Year	Citations

Page 1

Page 1